Related Experiment Video
Updated: May 22, 2025
Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
Published on: May 3, 2024
Small extracellular vesicles from young adipose-derived stem cells ameliorate age-related changes in the heart of old
Jorge Sanz-Ros1,2, Javier Huete-Acevedo1, Cristina Mas-Bargues1
1MiniAging Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES, INCLIVA, Avenida Blasco Ibáñez, 15, Valencia, Spain.
Background:
Aging entails a progressive decline in physiological functions, elevating the risk of age-related diseases like heart failure or aortic stenosis. Stem cell therapies, especially those that use paracrine signaling, can potentially mitigate the adverse effects of aging.
Objectives:
The objective is to explore the potential of small extracellular vesicles (sEVs) derived from young adipose-derived stem cells (ADSC-sEVs) in reversing structural, molecular, and functional changes associated with aging in the heart.
Methods:
Aged C57BL/6J mice were treated intravenously with ADSC-sEVs from young mice or PBS as controls. Young mice were included to identify specific age-associated changes. The impact of sEV treatment on cardiac function was assessed using transthoracic echocardiography and physical endurance tests. Histological and molecular analyses were conducted on heart tissue to evaluate structural changes and markers of senescence, inflammation, and oxidative stress. A comprehensive metabolomic analysis was also performed on heart tissues to identify changes in metabolic profiles associated with aging and treatment status.
Results:
The administration of ADSC-sEVs significantly improves several aging-associated cardiac parameters, including oxidative stress, inflammation, and cellular senescence reductions. We also report on the age-related reversal of myocardial structure and function changes, highlighted by decreased fibrosis and improved vascularization. Notably, echocardiographic assessments reveal that sEV treatments ameliorate diastolic dysfunction and left ventricle structural alterations typically associated with aging. Furthermore, the treatment shifts the heart metabolome towards a more youthful profile.
Conclusions:
These results denote the potential of ADSC-sEVs as a novel, noninvasive therapeutic strategy for mitigating cardiac aging-associated functional decline.
Insights
Young stem cell-derived extracellular vesicles (sEVs) rejuvenate aging hearts by reducing oxidative stress, inflammation, and fibrosis. This therapy improves cardiac structure and function, offering a promising approach for age-related heart decline.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Aging Research
Background:
- Aging leads to physiological decline and increased risk of heart diseases.
- Stem cell therapies, particularly paracrine signaling, show potential in combating aging effects.
Purpose of the Study:
- To investigate if small extracellular vesicles (sEVs) from young adipose-derived stem cells (ADSC-sEVs) can reverse cardiac aging.
- To assess the impact of ADSC-sEVs on structural, molecular, and functional heart changes in aged mice.
Main Methods:
- Aged mice received intravenous ADSC-sEVs or PBS; young mice served as controls.
- Cardiac function assessed via echocardiography and endurance tests.
- Heart tissues analyzed for senescence, inflammation, oxidative stress, fibrosis, vascularization, and metabolomics.
Main Results:
- ADSC-sEVs treatment reduced cardiac oxidative stress, inflammation, and senescence.
- Improved myocardial structure and function, with decreased fibrosis and enhanced vascularization.
- Echocardiography showed ameliorated diastolic dysfunction and left ventricle alterations; metabolomics revealed a shift towards a youthful cardiac profile.
Conclusions:
- ADSC-sEVs show potential as a novel therapeutic strategy.
- This noninvasive approach may mitigate age-related cardiac functional decline.
